These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 35222442)
1. Corrigendum: A Perspective on the Success and Failure of BCG. Kumar P Front Immunol; 2022; 13():850325. PubMed ID: 35222442 [TBL] [Abstract][Full Text] [Related]
2. A Perspective on the Success and Failure of BCG. Kumar P Front Immunol; 2021; 12():778028. PubMed ID: 34970263 [TBL] [Abstract][Full Text] [Related]
3. How to avoid the impact of environmental mycobacteria towards the efficacy of BCG vaccination against tuberculosis? Parkash O Int J Mycobacteriol; 2014 Mar; 3(1):1-4. PubMed ID: 26786215 [TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Abubakar I; Pimpin L; Ariti C; Beynon R; Mangtani P; Sterne JA; Fine PE; Smith PG; Lipman M; Elliman D; Watson JM; Drumright LN; Whiting PF; Vynnycky E; Rodrigues LC Health Technol Assess; 2013 Sep; 17(37):1-372, v-vi. PubMed ID: 24021245 [TBL] [Abstract][Full Text] [Related]
5. The success and failure of BCG - implications for a novel tuberculosis vaccine. Andersen P; Doherty TM Nat Rev Microbiol; 2005 Aug; 3(8):656-62. PubMed ID: 16012514 [TBL] [Abstract][Full Text] [Related]
6. Corrigendum: ACTIVATE-2: A double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk. Tsilika M; Taks E; Dolianitis K; Kotsaki A; Leventogiannis K; Damoulari C; Kostoula M; Paneta M; Adamis G; Papanikolaou I; Stamatelopoulos K; Bolanou A; Katsaros K; Delavinia C; Perdios I; Pandi A; Tsiakos K; Proios N; Kalogianni E; Delis I; Skliros E; Akinosoglou K; Perdikouli A; Poulakou G; Milionis H; Athanassopoulou E; Kalpaki E; Efstratiou L; Perraki V; Papadopoulos A; Netea MG; Giamarellos-Bourboulis EJ Front Immunol; 2022; 13():1018384. PubMed ID: 36119100 [TBL] [Abstract][Full Text] [Related]
7. The geographic location (latitude) of studies evaluating protective effect of BCG vaccine and it's efficacy/effectiveness against tuberculosis. Zodpey SP; Shrikhande SN Indian J Public Health; 2007; 51(4):205-10. PubMed ID: 18232158 [TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB. Cheng P; Jiang F; Wang G; Wang J; Xue Y; Wang L; Gong W Front Immunol; 2023; 14():1154693. PubMed ID: 36845146 [TBL] [Abstract][Full Text] [Related]
9. Corrigendum: Use of UV Treated Milk Powder to Increase Vaccine Efficacy in the Elderly. Schaefer S; Hettinga KA; Cullor J; German JB; Henrick BM Front Immunol; 2019; 10():427. PubMed ID: 30936865 [TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes. Jeyanathan V; Afkhami S; D'Agostino MR; Zganiacz A; Feng X; Miller MS; Jeyanathan M; Thompson MR; Xing Z Front Immunol; 2023; 14():1151809. PubMed ID: 36825013 [TBL] [Abstract][Full Text] [Related]
11. Geographic latitude and the efficacy of bacillus Calmette-Guérin vaccine. Wilson ME; Fineberg HV; Colditz GA Clin Infect Dis; 1995 Apr; 20(4):982-91. PubMed ID: 7795103 [TBL] [Abstract][Full Text] [Related]
12. Corrigendum: Recent Progress in Recombinant Influenza Vaccine Development Toward Heterosubtypic Immune Response. Carascal MB; Pavon RDN; Rivera WL Front Immunol; 2022; 13():948031. PubMed ID: 35769471 [TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Shim D; Kim H; Shin SJ Front Immunol; 2020; 11():1601. PubMed ID: 32765536 [TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Pediatric Burn Survivors Have Long-Term Immune Dysfunction With Diminished Vaccine Response. Johnson BZ; McAlister S; McGuire HM; Palanivelu V; Stevenson A; Richmond P; Palmer DJ; Metcalfe J; Prescott SL; Wood FM; Fazekas de St Groth B; Linden MD; Fear MW; Fear VS Front Immunol; 2020; 11():598646. PubMed ID: 33163008 [TBL] [Abstract][Full Text] [Related]
15. Corrigendum: A Meta-Analysis of the Effect of Bacillus Calmette-Guérin Vaccination Against Bovine Tuberculosis: Is Perfect the Enemy of Good? Srinivasan S; Conlan AJK; Easterling LA; Herrera C; Dandapat P; Veerasami M; Ameni G; Jindal N; Raj GD; Wood J; Juleff N; Bakker D; Vordermeier M; Kapur V Front Vet Sci; 2021; 8():716565. PubMed ID: 34395582 [TBL] [Abstract][Full Text] [Related]
16. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819 [TBL] [Abstract][Full Text] [Related]
17. Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions. Verma D; Chan ED; Ordway DJ Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33207695 [TBL] [Abstract][Full Text] [Related]
18. Next-Generation Vaccines Based on Bacille Calmette-Guérin. Nieuwenhuizen NE; Kaufmann SHE Front Immunol; 2018; 9():121. PubMed ID: 29459859 [TBL] [Abstract][Full Text] [Related]
19. Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis. Price DN; Kusewitt DF; Lino CA; McBride AA; Muttil P PLoS Pathog; 2016 May; 12(5):e1005614. PubMed ID: 27153120 [TBL] [Abstract][Full Text] [Related]
20. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection. Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]